PharmiWeb.com - Global Pharma News & Resources
11-Feb-2019

Conference Call Regarding Elekta's Q3 Report for 2018/19

STOCKHOLM, Feb. 11, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) will publish its Q3 report for 2018/19 on February 22, as per:

  • The report will be published at 07:30 CET.
  • Elekta will host a telephone conference starting at 10:00 CET with Richard Hausmann, President and CEO, and Gustaf Salford, CFO.

To take part in the conference call, please dial in about five minutes in advance.

  • UK dial-in number: +44(0)333-300-9265
  • US dial-in number: +1-646-722-4902
  • Swedish dial-in number: +46(0)8-505-583-50

The telephone conference will also be broadcasted live online, through the following link (however, in order to ask questions, it is necessary to call in):
http://event.on24.com/wcc/r/1919136-1/CA7E707987FE9817758D6C8899341F6F 

About Elekta

For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

For further information, please contact:
Oskar Bosson, Global EVP Corporate Communications and Investor Relations
Tel: +46-70-410-7180, E-mail: Oskar.Bosson@elekta.com
Time zone: CET: Central European Time

Gunilla Öhman, Head of Investor Relations (interim)
Tel: +46-70-763-8125, E-mail: gunilla.oehman@elekta.com
Time zone: CET: Central European Time

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/elekta/r/conference-call-regarding-elekta-s-q3-report-for-2018-19,c2736645

The following files are available for download:

https://mb.cision.com/Main/35/2736645/988488.pdf

PDF

 

Editor Details

Last Updated: 11-Feb-2019